Current Research on GLP-1 Drugs and Muscle Mass A 2022 systematic review in Obesity Reviews found that GLP-1 medication-associated weight loss showed comparable or slightly better muscle preservation than diet-only approaches
10.1016/j.cmet.2013.01.003 86 SegalL
Ingredients Water, ethylhexyl palmitate, squalane, stearic acid, Copper Tripeptide-1 (GHK-Cu), methylsulfonylmethane, dimethyl MEA (DMAE), cetyl alcohol, glyceryl stearate, PEG-100 stearate, nannochloropsis oculata extract (with pullulan, aqua, phenoxyethanol, and sodium benzoate potassium sorbate), PPG 2 myristyl ether propionate, phenoxyethanol, C10-30 cholesterol/lanosterol esters, polysorbate 80, allantoin, leucine, lavandula angustifolia (lavender) oil, aloe barbadensis (aloe vera) powder, sodium salicylate, vitamin E TPGS (tocophersolan), vitamin E (as d-alpha tocopherol plus mixed tocopherols: d-beta, d-delta and d-gamma tocopherol)
S2CID 30993451
In the STEP 1 trial, semaglutide led to an average 14.9% reduction in body weight over 68 weeks , far outperforming placebo (NEJM study on semaglutide for weight loss)